Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
US-10028983-B2 · Jul 24, 2018 · US
Agent for improving mitochondrial function
US12083152B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12083152-B2 |
| Application number | US-201917279941-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 26, 2019 |
| Priority date | Sep 26, 2018 |
| Publication date | Sep 10, 2024 |
| Grant date | Sep 10, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a mitochondrial function-improving agent containing a lactic acid bacterium belonging to Lactobacillus farciminis or Pediococcus acidilactici , a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for improving mitochondrial function, comprising: administering a therapeutically effective amount of a lactic acid bacterium belonging to Lactobacillus farciminis or Pediococcus acidilactici , or a culture of the lactic acid bacterium, to a subject in need thereof, wherein the Lactobacillus farciminis is Lactobacillus farciminis OLL204082 strain, accession number: NITE BP-02635, or the Pediococcus acidilactici is Pediococcus acidilactici OB7260 strain, accession number: NITE BP-02634.
Assignees
Inventors
Classifications
Bacteria or derivatives thereof, e.g. probiotics · CPC title
Bacteria; Culture media therefor · CPC title
Anti-ageing preparations · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the nervous system · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12083152B2 cover?
- The present invention provides a mitochondrial function-improving agent containing a lactic acid bacterium belonging to Lactobacillus farciminis or Pediococcus acidilactici , a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium.
- Who is the assignee on this patent?
- Meiji Co Ltd, National Univ Corporation Hamamatsu Univ School Of Medicine
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).